Results 1 - 20 of 139 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Refined by:
resource type:
Reports
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Reports
|
|
Design, synthesis and biological evaluation of novel diosgenin-benzoic acid mustard hybrids with potential anti-proliferative activities in human hepatoma HepG2 cellsJournal of Enzyme Inhibition and Medicinal Chemistry, 2022, Vol.37 (1), p.1299-13142022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 1475-6366 ;EISSN: 1475-6374 ;DOI: 10.1080/14756366.2022.2070161Full text available |
| 2 |
Material Type: Reports
|
|
Campylobacter jejuni permeabilizes the host cell membrane by short chain lysophosphatidylethanolaminesGut Microbes, 2022, Vol.14 (1)2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 ;ISSN: 1949-0976 ;EISSN: 1949-0984 ;DOI: 10.1080/19490976.2022.2091371Full text available |
| 3 |
Material Type: Reports
|
|
Prospective Grant of an Exclusive Patent License: Antibody-Drug Conjugates (ADCs) for Targeting CD56-Positive TumorsThe Federal Register / FIND, 2024, Vol.89 (92), p.40495Copyright Federal Information & News Dispatch, LLC May 10, 2024 ;ISSN: 0097-6326 ;EISSN: 2167-2520Full text available |
| 4 |
Material Type: Reports
|
|
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodiesmAbs, 2019, Vol.11 (5), p.826-8362019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2019.1608143Full text available |
| 5 |
Material Type: Reports
|
|
High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functionsmAbs, 2023, Vol.15 (1)2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2023.2184197Full text available |
| 6 |
Material Type: Reports
|
|
Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalisJournal of Enzyme Inhibition and Medicinal Chemistry, 2022, Vol.37 (1), p.781-7912022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 1475-6366 ;EISSN: 1475-6374 ;DOI: 10.1080/14756366.2022.2041629Full text available |
| 7 |
Material Type: Reports
|
|
Mechanistic insights into the rational design of masked antibodiesmAbs, 2022, Vol.14 (1)2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2022.2095701Full text available |
| 8 |
Material Type: Reports
|
|
Universal antibody targeting the highly conserved fusion peptide provides cross-protection in miceHuman Vaccines & Immunotherapeutics, 2022, Vol.18 (5)2022 Crown Copyright. Published with license by Taylor & Francis Group, LLC. 2022 ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2022.2083428Full text available |
| 9 |
Material Type: Reports
|
|
Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphomaOncoImmunology, 2020, Vol.9 (1)2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 ;EISSN: 2162-402X ;DOI: 10.1080/2162402X.2020.1751561Full text available |
| 10 |
Material Type: Reports
|
|
Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoformsmAbs, 2019, Vol.11 (2), p.350-3722018 The Author(s). Published with license by Taylor & Francis Group, LLC. 2018 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1551044Full text available |
| 11 |
Material Type: Reports
|
|
Government-Owned Inventions; Availability for LicensingThe Federal Register / FIND, 2024, Vol.89 (32), p.11845Copyright Federal Information & News Dispatch, LLC Feb 15, 2024 ;ISSN: 0097-6326 ;EISSN: 2167-2520Full text available |
| 12 |
Material Type: Reports
|
|
Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases; Draft Guidance for Industry; AvailabilityThe Federal Register / FIND, 2023, Vol.88 (11), p.2932Copyright Federal Information & News Dispatch, LLC Jan 18, 2023 ;ISSN: 0097-6326 ;EISSN: 2167-2520Full text available |
| 13 |
Material Type: Reports
|
|
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment; Guidance for Industry; AvailabilityThe Federal Register / FIND, 2022, Vol.87 (200), p.63077Copyright Federal Information & News Dispatch, LLC Oct 18, 2022 ;ISSN: 0097-6326 ;EISSN: 2167-2520Full text available |
| 14 |
Material Type: Reports
|
|
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to ZenapaxmAbs, 2016, Vol.8 (7), p.1417-14242016 The Author(s). Published with license by Taylor & Francis Group, LLC © AbbVie Inc. 2016 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2016.1207031Full text available |
| 15 |
Material Type: Reports
|
|
A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivomAbs, 2014, Vol.6 (5), p.1265-12732014 Taylor & Francis Group, LLC 2014 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.4161/mabs.29825Full text available |
| 16 |
Material Type: Reports
|
|
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumorsmAbs, 2021, Vol.13 (1)2021 The Author(s). Published with license by Taylor & Francis Group, LLC. 2021 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2021.1950264Full text available |
| 17 |
Material Type: Reports
|
|
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment; Draft Guidance for Industry; AvailabilityThe Federal Register / FIND, 2020, Vol.85 (157), p.49383Copyright Federal Information & News Dispatch, LLC Aug 13, 2020 ;ISSN: 0097-6326 ;EISSN: 2167-2520Full text available |
| 18 |
Material Type: Reports
|
|
Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearancemAbs, 2018, Vol.10 (2), p.278-2892018 Taylor & Francis Group, LLC 2018 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2017.1402995Full text available |
| 19 |
Material Type: Reports
|
|
Glycosylation profile and biological activity of Remicade® compared with Flixabi® and RemsimamAbs, 2017, Vol.9 (6), p.968-9772017 The Author(s). Published with license by Taylor & Francis Group, LLC © Samsung Bioepis 2017 ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2017.1337620Full text available |
| 20 |
Material Type: Reports
|
|
Prospective Grant of Exclusive Patent License: Development, Commercial Application and Use of Fulvestrant in Combination Therapy for the Treatment of CancersThe Federal Register / FIND, 2017, Vol.82 (135), p.32712Copyright (c) 2017 Federal Information & News Dispatch, Inc. ;ISSN: 0097-6326 ;EISSN: 2167-2520Full text available |
Results 1 - 20 of 139 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 1988 (10)
- 1988 To 1997 (32)
- 1998 To 2005 (15)
- 2006 To 2014 (47)
- After 2014 (36)
-
More options
New Records
Subject
- Cytotoxicity (112)
- Toxicity (60)
- Medicine And Medical Research (59)
- Cells (51)
- Cytotoxins (37)
- Toxicology (37)
- Biochemistry (32)
- In Vitro Analysis (28)
- Pharmacology (25)
- Anatomy And Physiology (19)
- Humans (19)
- Breast Cancer (18)
- Pathology (18)
- Proteins (15)
- Response (14)
- Immunotherapy (14)
- Chemotherapy (13)
- Lymphocytes (13)
- Assaying (13)
- Metastasis (13)
-
More options
Databases
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||